Skip to main content
. 2025 Feb 12;81:103080. doi: 10.1016/j.eclinm.2025.103080

Table 2.

Effect of allocation to higher dose corticosteroid on key study outcomes.

Treatment allocation
RR (95% CI)
Higher dose steroids (n = 246) Usual care (n = 231)
Primary outcome
 28-day mortality 86 (35%) 86 (37%) 0.87 (0.64–1.18)
Secondary outcomes
 Time to being discharged alive, days (median [IQR]) 24 (12 to >28) 26 (11 to >28)
 Discharged from hospital within 28 days 128 (52%) 120 (52%) 1.04 (0.81–1.33)
 Receipt of invasive mechanical ventilation or deatha 76/206 (37%) 93/205 (45%) 0.79 (0.63–1.00)
 Invasive mechanical ventilation 29/206 (14%) 40/205 (20%) 0.72 (0.46–1.11)
 Death 65/206 (32%) 79/205 (39%) 0.80 (0.62–1.04)
Subsidiary clinical outcomes
 Successful cessation of invasive mechanical ventilationb 14/40 (35%) 11/26 (42%) 0.80 (0.36–1.80)
 Use of haemodialysis or haemofiltrationc 21/243 (9%) 18/229 (8%) 0.97 (0.54–1.74)

Data are n (%) or n/N (%), unless otherwise indicated. RR = rate ratio for the outcomes of 28-day mortality and hospital discharge, and risk ratio for other outcomes. CI = confidence interval. Estimates of the RR and its 95% CI are adjusted for age in three categories (<70 years, 70–79 years, and 80 years or older) and ventilation status at randomisation in two categories (non-invasive ventilation and invasive mechanical ventilation).

a

Analyses exclude those on invasive mechanical ventilation at randomisation.

b

Analyses restricted to those on invasive mechanical ventilation at randomisation.

c

Analyses exclude those on haemodialysis or haemofiltration at randomisation.